3DPOD Episode 213: 3D Printed Personalized Medicine with Wei Jiang, Craft Health
Wei Jiang founded medicine 3D printing startup Craft Health as a Pharmacy student. I love it when practitioners and people from other backgrounds establish 3D printing companies. It often leads to user-driven companies that cater well to those trying to use additive manufacturing. In this episode of the 3DPOD, we follow Craft Health’s journey from inception to funding and the release of the firm’s 3D printer for pharmaceuticals. We discuss release kinetics, approvals, drug delivery, compounding pharmacies, dosage forms, polypills, delayed release, nutrition, dementia care, and much more. 3D printing for pharmaceuticals has significant potential, and not enough people are paying attention.
Podcast: Play in new window | Download
Podcast (podcast-audio): Play in new window | Download
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
Print Services
You May Also Like
New Business: Temporary, Migratory, & Modular 3D Printed Architecture
If we look at potentially emerging 3D printing businesses, then architecture has not been fully explored. Yes, there is a lot of house 3D printing going on worldwide. From deployable...
3D Printing News Briefs, April 19, 2025: Material Extrusion Standard, Metal Powder, & More
In today’s 3D Printing News Briefs, we’re covering a proposed standard for material extrusion, before moving on to business and metal powder. We’ll end with a commercial store’s robotic 3D...
Japan Unveils World’s First 3D Printed Train Station
Japan is now home to what we believe is the world’s first train station built with 3D printing technology. Located in Arida City, just south of Osaka, the new Hatsushima...
restor3d Raises $38M to Expand 3D Printed Orthopedic Implants
Backed by $38 million in new funding, restor3d is pushing ahead with the launch of four personalized implant lines, set to roll out in 2025 and 2026. This latest venture...
